Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.09B | 16.61B | 16.29B | 16.40B | 17.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.09B | 16.61B | 16.29B | 16.40B | 17.28B |
| Cost of Revenue | 4.41B | 4.13B | 3.88B | 4.30B | 3.75B |
| Gross Profit | 13.67B | 12.48B | 12.41B | 12.11B | 13.53B |
| SG&A Expenses | 2.77B | 2.78B | 2.57B | 2.73B | 2.48B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.72B | 16.65B | 10.00B | 11.03B | 10.23B |
| Operating Income | 6.37B | -40.00M | 6.29B | 5.38B | 7.05B |
| Income Before Tax | 5.56B | -683.00M | -3.53B | 3.42B | 6.75B |
| Income Tax Expenses | 492.00M | 654.00M | 709.00M | 458.00M | 958.00M |
| Earnings from Continuing Operations | 5.07B | -1.34B | -4.24B | 2.96B | 5.79B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.00M | 2.00M | 3.00M | 1.00M | -2.00M |
| Net Income | 5.07B | -1.34B | -4.24B | 2.96B | 5.79B |
| EBIT | 6.37B | -40.00M | 6.29B | 5.38B | 7.05B |
| EBITDA | 7.88B | 1.43B | 7.69B | 6.79B | 8.15B |
| EPS Basic | 2.05 | -0.54 | -1.72 | 1.19 | 2.32 |
| Normalized Basic EPS | 1.47 | -0.13 | 1.48 | 1.25 | 1.69 |
| EPS Diluted | 2.04 | -0.54 | -1.72 | 1.19 | 2.32 |
| Normalized Diluted EPS | 1.47 | -0.13 | 1.48 | 1.25 | 1.69 |
| Average Basic Shares Outstanding | 2.47B | 2.47B | 2.47B | 2.49B | 2.50B |
| Average Diluted Shares Outstanding | 2.48B | 2.47B | 2.47B | 2.49B | 2.50B |
| Dividend Per Share | 0.85 | 0.85 | 0.85 | 0.81 | 0.81 |
| Payout Ratio | 41.44% | -160.60% | -49.65% | 68.11% | 35.11% |